Tango Therapeutics's total assets for Q3 2024 were $352.42M, a decrease of -7.61% from the previous quarter. TNGX total liabilities were $123.25M for the fiscal quarter, a -7.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.